Xcout IntelSIDERO BIOSCIENCE, LLC
Sidero Bioscience is a clinical-stage biotechnology company that develops natural iron supplement products to address iron deficiency and nutritional health. Its proprietary SideroSorb platform and BioFe iron complex utilize a unique uptake mechanism designed to improve absorption and minimize gastrointestinal side effects compared to traditional iron therapies.
Subscribe to see SIDERO BIOSCIENCE, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
SIDERO BIOSCIENCE, LLC at a glance
SIDERO BIOSCIENCE, LLC is a biotechnology company headquartered in United States. Its most recent funding round raised $145,000 in October 2016. Xcout tracks 6 named people at SIDERO BIOSCIENCE, LLC, including Robert E. Harbaugh (Chief Operating Officer, Member of the Board of Directors).
SIDERO BIOSCIENCE, LLC leadership
- Robert E. HarbaughChief Operating Officer, Member of the Board of Directors
- Michael ArmstrongChief Financial Officer, Member of the Board of Directors
- Ifukibot Levi UsendeChief Scientist
- Ralph L. KeilSenior Vice President of Research
- James ConnorFounder and Chairman of the Board of Directors
- Silvan B. Lutkewitte, IIIExecutive Officer
SIDERO BIOSCIENCE, LLC funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $145,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
SIDERO BIOSCIENCE, LLC competitors
A few of SIDERO BIOSCIENCE, LLC's closest competitors — see the full list of competitors and alternatives →
Ferrosa Therapeutics AG is a Swiss biotechnology company founded in Basel, Switzerland, focusing on developing novel therapeutics to treat anemia and related conditions.
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Keros Therapeutics is a clinical-stage biopharmaceutical company that develops novel therapeutics targeting the transforming growth factor-beta (TGF-ß) superfamily of proteins. The company focuses on creating treatments for patients with hematological and neuromuscular disorders linked to dysfunctional protein signaling.
Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Federation Bio is a U.S. biotechnology company developing live biotherapeutic products based on defined microbial communities to treat diseases. Its work has focused on microbiome-based therapies for metabolic and other serious disorders, serving patients with conditions that may benefit from engineered microbial consortia.
Scarlet Therapeutics, founded in 2021 and headquartered in Bristol, United Kingdom, is developing a pioneering platform that generates novel red blood cell-based therapeutics to treat a wide range of diseases.
Get SIDERO BIOSCIENCE, LLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on SIDERO BIOSCIENCE, LLC in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access